Navigation Links
SpiderTech Announces Kinesiology Tape Breakthrough, SpiderTech Gentle – Kinesiology Tape for Even the Most Sensitive Skin
Date:4/21/2010

SpiderTech is pleased to announce a new breakthrough product for Kinesiology Tape Therapy – SpiderTech Gentle. Developed by Nitto Denko, the original manufacturers of Kinesiology Tape products, SpiderTech Gentle was created for patients with sensitive skin.

(PRWEB) April 21, 2010 -- SpiderTech is pleased to announce a new breakthrough product for Kinesiology Tape Therapy – SpiderTech Gentle. Developed by Nitto Denko, the original manufacturers of Kinesiology Tape products, SpiderTech Gentle was created for patients with sensitive skin.

SpiderTech Gentle products are scientifically formulated to minimize skin irritation through the use of Nitto Denko’s new Stratagel adhesive, reducing redness and itching typical to patients with low collagen, fragile, or sensitive skin. Stratagel combines a lower level of adhesive force with a pliability that allows the adhesive to conform to the micro-contours of human skin, generating a gentle adhesion that fixes the tape firmly, but reduces stress on the skin during wear and at removal.

"The new SpiderTech Gentle truly is a breakthrough product," states Dr. Kevin Jardine, SpiderTech CMO. “Nitto Denko’s StrataGeltm adhesive has allowed us to use SpiderTech Gentle on selected professional athletes with skin sensitivities, demonstrating its ability to adhere in extreme applications, as well as use it in-clinic on our patents with markedly lower levels of collagen to great success.”

SpiderTech Gentle is water resistant and is designed to remain on the skin for up to 3 days or more. Excellent for use with patients that exhibit skin irritation with standard Kinesiology tape products, SpiderTech Gentle allows for continuous application on patients with chronic conditions.

SpiderTech Gentle is available in the complete line of SpiderTech pre-cut, ready –to-apply products, and SpiderTape rolls, making it the perfect addition to Geriatric and Pediatric-focused practices and facilities. The entire range of SpiderTech Gentle Pre-Cuts is now available for order. For more information on the

SpiderTech Gentle products, visit www.nucapmedical.com/products-gentle.html, or contact your SpiderTech Distribution Partner representative

For more information on SpiderTech, Contact SpiderTech Customer Service, customerservice(at)spidertech(dot)com

About SpiderTech
SpiderTech is the developer and world leader of , pre-cut and ready to apply kinesiology taping applications in a single piece. SpiderTech is committed to excellence and innovation in the management of pain and myofascial dysfunction through the use of specialized elastic tape applications. SpiderTech’s focus is on the development and manufacturing of products and therapy protocols that meet the demands of today’s health care clinician and therapist.

# # #

Read the full story at http://www.prweb.com/releases/product/gentle/prweb3904004.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Team SpiderTech Powered by Planet Energy Makes the Amgen Tour of California Guest List
2. SpiderTech Rides the Night Train to Olympic Gold
3. Mercy Ships Announces Sierra Leone Field Service
4. USA TODAY Announces Results Of Twitter Hashtag Campaign For Charity
5. MaxID Corp Announces Webinar Series Focused on Identity and Security -- Webinars Cover Topics of TWIC Compliance, Biometrics, Identity Dominance
6. Tarascon Announces New Title In Their Pocketbook Series: Global Health
7. NY A's Pro Hockey Team Announces Ticket Pricing & Benefits
8. Dreambikes Announces Grand Opening Event
9. Maryland's Preeminent Domestic Violence Agency Announces New Organizational Changes
10. NuSil Technology Announces Completion of Clean Room Facilities
11. Dr. David Blyweiss Announces New IBS Relief Protocol
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
SpiderTech Announces Kinesiology Tape Breakthrough, SpiderTech Gentle – Kinesiology Tape for Even the Most Sensitive Skin
(Date:12/9/2016)... ... 09, 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) ... summer of 2016. The program was made possible by a Pennsylvania Department of ... Health and Human Services Administration. The broadcast, Use Your Head: Properly Managing ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Compensation Research Institute (WCRI) officially opened registration today for its 33rd Annual ... in Boston, MA . , The theme of the conference is “Persistent Challenges ...
(Date:12/8/2016)... PLAINS, N.Y., and JENNERSVILLE, Pa. (PRWEB) , ... ... ... to announce that Penn Medicine Southern Chester County, a Property owned by an ... The $23 million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care ...
(Date:12/8/2016)... , ... December 08, 2016 , ... With the increasing ... the “What’s In Your Mouth?” (WIYM) campaign to inform dentists and patients about the ... the dental implant and prosthetic market in the U.S. is projected to reach $6.4 ...
(Date:12/8/2016)... Tampa, Fla (PRWEB) , ... December 08, 2016 ... ... offering smarter modes of access for customers and employees that are both engaging ... ChangeGear 7 with Service Smart Technology, the software company revealed today its plans ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
(Date:12/8/2016)... Bodycad announced it has been awarded ... reproducibility and speed for 3D constructs via MRI ... orthopaedic applications. These patents are critical to the ... based on each patient,s distinct anatomy. ... the world,s first suite of orthopaedic CAD/CAM software. ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, ... has obtained proof-of-mechanism for neflamapimod (previously code named ... Phase 2a clinical trials that demonstrated significant Alzheimer,s ... 302 (12-week treatment) and Study 303 (6-week treatment) ... Trials in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: